208 related articles for article (PubMed ID: 8639404)
41. Socioeconomic disparities in musculoskeletal oncology.
Jawad MU; Theriault RV; Thorpe SW; Randall RL
J Surg Oncol; 2023 Sep; 128(3):425-429. PubMed ID: 37537984
[TBL] [Abstract][Full Text] [Related]
42. [Update on grading of bone and soft tissue tumors].
Ding Y; Wang J
Zhonghua Bing Li Xue Za Zhi; 2023 Jan; 52(1):3-6. PubMed ID: 36617898
[TBL] [Abstract][Full Text] [Related]
43. Interventional Techniques for Bone and Musculoskeletal Soft Tissue Tumors: Current Practices and Future Directions - Part II. Stabilization.
Dalili D; Isaac A; Cazzato RL; Åström G; Bergh J; Mansour R; Weber MA; Garnon J; Gangi A
Semin Musculoskelet Radiol; 2020 Dec; 24(6):710-725. PubMed ID: 33307586
[TBL] [Abstract][Full Text] [Related]
44. CORR Insights®: Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
Iwata S
Clin Orthop Relat Res; 2024 Mar; 482(3):564-565. PubMed ID: 38289700
[No Abstract] [Full Text] [Related]
45. Identified Enrollment Challenges of Adolescent and Young Adult Patients on the Nonchemotherapy Arm of Children's Oncology Group Study ARST1321.
Avutu V; Weiss AR; Reed DR; Ahmed SK; Allen-Rhoades WA; Chen YE; Davis LE; Eaton BR; Hawkins DS; Indelicato DJ; Patel SR; Randall RL; Reinke DK; Riedel RF; Scharschmidt TJ; Thornton KA; Wang D; Janeway KA; Kopp LM
J Adolesc Young Adult Oncol; 2022 Jun; 11(3):328-332. PubMed ID: 34515544
[TBL] [Abstract][Full Text] [Related]
46. [Sar'connect a mobile app to enhance soft-tissue sarcoma patients' referral to expert centers].
Nannini S; Gantzer J; Tetreau R; Blay JY; Kurtz JE
Bull Cancer; 2021 Dec; 108(12):1181-1183. PubMed ID: 34756597
[No Abstract] [Full Text] [Related]
47. PD-1 inhibition in bone sarcoma and soft-tissue sarcoma.
Mir O; Honoré C; Adam J
Lancet Oncol; 2017 Nov; 18(11):1430-1431. PubMed ID: 28988645
[No Abstract] [Full Text] [Related]
48. Validity and completeness of the Scandinavian Sarcoma Group Central Register by comparison with a nationwide cohort of patients with osteosarcoma in Norway.
Zaikova O; Berner K
J Surg Oncol; 2018 Jul; 118(1):248. PubMed ID: 30208204
[No Abstract] [Full Text] [Related]
49. [Sarcoma-Established and new aspects and challenges in multimodal management].
Bruns CJ
Chirurg; 2019 Jun; 90(6):439-440. PubMed ID: 31187213
[No Abstract] [Full Text] [Related]
50. Editorial: precision medicine of sarcomas and aggressive connective tissue tumours: from one-size-fits-all to haute couture.
Blay JY
Curr Opin Oncol; 2022 Jul; 34(4):320-321. PubMed ID: 35837702
[No Abstract] [Full Text] [Related]
51. [Ⅱ.MSK-IMPACT of Bone and Soft Tissue Sarcomas in Japan].
Suehara Y; Hayashi T; Saito T; Kato S; Ladanyi M
Gan To Kagaku Ryoho; 2020 Mar; 47(3):428-435. PubMed ID: 32381909
[No Abstract] [Full Text] [Related]
52. Skeletal Sarcomas: Diagnosis, Treatment, and Follow-up from the Orthopedic Oncologist Perspective.
Goulding KA; Wilke BK; Kiernan HC; Houdek MT; Sherman CE
Radiol Clin North Am; 2022 Mar; 60(2):193-203. PubMed ID: 35236588
[TBL] [Abstract][Full Text] [Related]
53. Hip pain in young adults: consider primary bone sarcoma.
Ashford RU; Eastley NC
BMJ; 2018 Aug; 362():k3191. PubMed ID: 30068660
[No Abstract] [Full Text] [Related]
54. [Ⅲ. Recent Trends in AI Technology in Bone and Soft Tissue Tumors].
Hasei J
Gan To Kagaku Ryoho; 2024 Mar; 51(3):263-268. PubMed ID: 38494806
[No Abstract] [Full Text] [Related]
55. The evolving management of epithelioid sarcoma.
Alves A; Constantinidou A; Thway K; Fisher C; Huang P; Jones RL
Eur J Cancer Care (Engl); 2021 Nov; 30(6):e13489. PubMed ID: 34278633
[No Abstract] [Full Text] [Related]
56. Treatment-related thoracic soft tissue sarcomas in survivors of breast cancer.
Hu X; Fujiwara T; Sun Y; Huang W; Yan W
Lancet Oncol; 2023 Jan; 24(1):e6. PubMed ID: 36603929
[No Abstract] [Full Text] [Related]
57. Targeting fusion proteins: a double edge sword?
Tirado OM
Expert Opin Ther Targets; 2019 Aug; 23(8):651-654. PubMed ID: 31167577
[No Abstract] [Full Text] [Related]
58. Improving at a nationwide level the management of patients with sarcomas with an expert network.
Blay JY; Penel N; Gouin F; Le Cesne A; Toulmonde M
Ann Oncol; 2022 Jun; 33(6):659-661. PubMed ID: 35219775
[No Abstract] [Full Text] [Related]
59. The Ever-Evolving Landscape of Sarcomas: A 2022 Update on This Complex Family of Diseases.
Raut CP; Gronchi A
Surg Oncol Clin N Am; 2022 Jul; 31(3):xvii-xix. PubMed ID: 35715152
[No Abstract] [Full Text] [Related]
60. The Ever-Evolving Landscape of Sarcomas: A 2022 Update on This Complex Family of Diseases.
Pawlik TM
Surg Oncol Clin N Am; 2022 Jul; 31(3):xv-xvi. PubMed ID: 35715151
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
